Erian Mark, McLaren Glenda, Baartz David
High Doctorate of Medicine, University of Queensland, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
JSLS. 2011 Jan-Mar;15(1):127-30. doi: 10.4293/108680811X13022985131732.
Levonorgestrel-containing intrauterine contraceptive devices, marketed as Mirena (Bayer HealthCare Pharmaceuticals, Inc. Australia) are widely used in contemporary gynecology, primarily as an effective method for contraception and for control of menstrual disorders like menorrhagia and dysmenorrhea. In this article, the authors report 2 cases of Mirena migration following intrauterine insertion by general practitioners (family physicians). In the first case, the contraceptive device had moved to the patient's right iliac fossa just anterior to the cecum and, in the second, within the peritoneal cavity close to the left leaf of the diaphragm. Both patients underwent uneventful laparoscopic retrieval of the devices.
含左炔诺孕酮的宫内节育器,商品名为曼月乐(拜耳医疗保健制药公司澳大利亚分公司),在当代妇科中广泛使用,主要作为一种有效的避孕方法,用于控制月经过多和痛经等月经紊乱。在本文中,作者报告了2例由全科医生(家庭医生)宫内放置曼月乐后发生移位的病例。第一例中,避孕装置移至患者右髂窝,恰好在盲肠前方;第二例中,移至腹膜腔内靠近膈肌左叶处。两名患者均通过腹腔镜顺利取出了节育器。